{"id":922,"date":"2026-04-17T13:00:41","date_gmt":"2026-04-17T13:00:41","guid":{"rendered":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/"},"modified":"2026-06-16T04:30:16","modified_gmt":"2026-06-16T04:30:16","slug":"beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada","status":"publish","type":"post","link":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/","title":{"rendered":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada"},"content":{"rendered":"<div data-type=\"ai_suggestion\" data-blockid=\"ae2df7d0-f62b-462d-ad9f-65fce89cd1dd\" data-uuid=\"\" data-aisuggestionrequestid=\"16804894\" data-contentdata='[{\"type\":\"paragraph\",\"attrs\":{\"blockId\":\"replaceWithId\",\"trackedChanges\":null,\"alignment\":null,\"depth\":0}}]'>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">\n<\/div>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-922","post","type-post","status-publish","format-standard","hentry","category-medical-desvice-registration"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Arora 297 Consultancy - Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-04-17T13:00:41+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-16T04:30:16+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/consultingwithoutboundaries\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#blogposting\",\"name\":\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy\",\"headline\":\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada\",\"author\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.arora297consultancy.com\\\/assets\\\/media\\\/general\\\/logo.png\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#articleImage\"},\"datePublished\":\"2026-04-17T13:00:41+00:00\",\"dateModified\":\"2026-06-16T04:30:16+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#webpage\"},\"articleSection\":\"Medical Device Establishment License\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/medical-desvice-registration\\\/#listItem\",\"name\":\"Medical Device Establishment License\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/medical-desvice-registration\\\/#listItem\",\"position\":2,\"name\":\"Medical Device Establishment License\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/medical-desvice-registration\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#listItem\",\"name\":\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#listItem\",\"position\":3,\"name\":\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/medical-desvice-registration\\\/#listItem\",\"name\":\"Medical Device Establishment License\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\",\"name\":\"Arora 297 Consultancy\",\"description\":\"Senior-led Health Canada and FDA regulatory consulting for medical devices, natural health products, cosmetics, food, and biocides \\u2014 backed by 20+ years of experience, 1,000+ successful submissions, and a 98% audit success rate. Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance Health Canada &amp; FDA Regulatory Consulting\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/\",\"email\":\"info@arora297consultancy.com\",\"telephone\":\"+15194985957\",\"foundingDate\":\"2020-01-23\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":2,\"maxValue\":4},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.arora297consultancy.com\\\/assets\\\/media\\\/general\\\/logo.png\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/consultingwithoutboundaries\\\/\",\"https:\\\/\\\/www.instagram.com\\\/arora297consultancy\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/arora-297-consultancy\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9c4b4c0b5727c4eaa4bbf02b476c099d4d7bb4a1fdceeafb6890a386e37d0bc6?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#webpage\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/\",\"name\":\"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2026-04-17T13:00:41+00:00\",\"dateModified\":\"2026-06-16T04:30:16+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/\",\"name\":\"Arora 297 Consultancy\",\"alternateName\":\"A297C\",\"description\":\"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy","description":"","canonical_url":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#blogposting","name":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy","headline":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada","author":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/arora297consultancy.com\/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","@id":"https:\/\/arora297consultancy.com\/blog\/#articleImage"},"datePublished":"2026-04-17T13:00:41+00:00","dateModified":"2026-06-16T04:30:16+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#webpage"},"isPartOf":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#webpage"},"articleSection":"Medical Device Establishment License"},{"@type":"BreadcrumbList","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog#listItem","position":1,"name":"Home","item":"https:\/\/arora297consultancy.com\/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/medical-desvice-registration\/#listItem","name":"Medical Device Establishment License"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/medical-desvice-registration\/#listItem","position":2,"name":"Medical Device Establishment License","item":"https:\/\/arora297consultancy.com\/blog\/category\/medical-desvice-registration\/","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#listItem","name":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#listItem","position":3,"name":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada","previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/medical-desvice-registration\/#listItem","name":"Medical Device Establishment License"}}]},{"@type":"Organization","@id":"https:\/\/arora297consultancy.com\/blog\/#organization","name":"Arora 297 Consultancy","description":"Senior-led Health Canada and FDA regulatory consulting for medical devices, natural health products, cosmetics, food, and biocides \u2014 backed by 20+ years of experience, 1,000+ successful submissions, and a 98% audit success rate. Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance Health Canada &amp; FDA Regulatory Consulting","url":"https:\/\/arora297consultancy.com\/blog\/","email":"info@arora297consultancy.com","telephone":"+15194985957","foundingDate":"2020-01-23","numberOfEmployees":{"@type":"QuantitativeValue","minValue":2,"maxValue":4},"logo":{"@type":"ImageObject","url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#organizationLogo"},"image":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/consultingwithoutboundaries\/","https:\/\/www.instagram.com\/arora297consultancy\/","https:\/\/www.linkedin.com\/company\/arora-297-consultancy\/"]},{"@type":"Person","@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author","url":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/9c4b4c0b5727c4eaa4bbf02b476c099d4d7bb4a1fdceeafb6890a386e37d0bc6?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#webpage","url":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/","name":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/arora297consultancy.com\/blog\/#website"},"breadcrumb":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/#breadcrumblist"},"author":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"creator":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"datePublished":"2026-04-17T13:00:41+00:00","dateModified":"2026-06-16T04:30:16+00:00"},{"@type":"WebSite","@id":"https:\/\/arora297consultancy.com\/blog\/#website","url":"https:\/\/arora297consultancy.com\/blog\/","name":"Arora 297 Consultancy","alternateName":"A297C","description":"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","inLanguage":"en-US","publisher":{"@id":"https:\/\/arora297consultancy.com\/blog\/#organization"}}]},"og:locale":"en_US","og:site_name":"Arora 297 Consultancy - Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","og:type":"article","og:title":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy","og:url":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/","og:image":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","og:image:secure_url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","article:published_time":"2026-04-17T13:00:41+00:00","article:modified_time":"2026-06-16T04:30:16+00:00","article:publisher":"https:\/\/www.facebook.com\/consultingwithoutboundaries\/","twitter:card":"summary_large_image","twitter:title":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada - Arora 297 Consultancy","twitter:image":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png"},"aioseo_meta_data":{"post_id":"922","title":"#post_title #separator_sa #site_title","description":"#post_excerpt","keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-05-26 18:05:41","updated":"2026-06-23 14:10:47","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\/category\/medical-desvice-registration\/\" title=\"Medical Device Establishment License\">Medical Device Establishment License<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tBeyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/arora297consultancy.com\/blog"},{"label":"Medical Device Establishment License","link":"https:\/\/arora297consultancy.com\/blog\/category\/medical-desvice-registration\/"},{"label":"Beyond Approval: Postmarket Regulatory Obligations for Drugs, Medical Devices, NHPs, and Cosmetics in the US and Canada","link":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-postmarket-regulatory-obligations-for-drugs-medical-devices-nhps-and-cosmetics-in-the-us-and-canada\/"}],"_links":{"self":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/comments?post=922"}],"version-history":[{"count":1,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/922\/revisions"}],"predecessor-version":[{"id":984,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/922\/revisions\/984"}],"wp:attachment":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/media?parent=922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/categories?post=922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/tags?post=922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}